Hepatitis C Management in Special Populations
Summary
- HCV transmission is most efficient through percutaneous exposure to contaminated blood, which is often present in needles and drug preparation materials shared among PWID[Zibbell 2015; Doerrbecker 2013]
- The WHO estimates that 5.6 million (8%) of the 71 million individuals with chronic HCV infection worldwide are currently engaged with IDU, whereas a greater yet undefined proportion were formerly engaged with IDU[WHO 2017]
- HCV prevalence is greater among PWID, with seroprevalence rates of 10% to 70% among PWID in the US and Europe[AASLD-IDSA HCV]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content